Abstract
American cutaneous leishmaniasis (ACL) is an endemic disease caused by Leishmania parasites. The ACL diagnosis is commonly accomplished by parasitological and immunological methods. The objective of this work was to evaluate the enzyme immunoassay (EIA) for ACL laboratorial diagnosis. IgG antibodies against Leishmania (Viannia) braziliensis promastigotes were researched. For the method standardization 240 sera were used: 72 from patients with positive parasitological diagnosis, 38 from normal individuals and 113 from individuals with other pathologies. The sensibility was 93% and the specificity was 70%. Regarding diagnosis, EIA showed 97% positivity in patients with ACL and 97% negativity in patients with other cutaneous lesions. The EIA presented a good performance when used for diagnosis, thus, it may become an important tool for it and for further ACL epidemiological studies in endemic areas. © 2007 by The Brazilian Journal of Infectious Diseases and Contexto Publishing. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Yoneyama, K. A. G., de Peder, L. D., Lonardoni, M. V. C., & Silveira, T. G. V. (2007). Diagnosis of American cutaneous leishmaniasis by enzyme immunoassay in patients from Northern Paraná State, Brazil. Brazilian Journal of Infectious Diseases, 11(3), 360–364. https://doi.org/10.1590/S1413-86702007000300012
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.